DERMAVANT HOLDINGS LIMITED
Get an alert when DERMAVANT HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-22 (in 3mo)
Last made up 2025-08-08
Watchouts
Cash
£85K
Latest balance sheet
Net assets
£64M
Equity attributable
Employees
0
Average over period
Profit before tax
-£64M
Period ending 2024-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2024-03-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£24,463 | -£57,821 | |
| Profit before tax | -£24,463 | -£64,306,153 | |
| Net profit | -£24,463 | -£64,171,979 | |
| Cash | £34,099 | £85,248 | |
| Total assets less current liabilities | £246,108 | £64,418,087 | |
| Net assets | £246,108 | £64,418,087 | |
| Equity | £246,108 | £64,418,087 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -9.9% | -0.1% | |
| Current ratio | -4.72x | -394.64x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Organon & Co. (hereafter called "the Group") financial position is allowing the Company to maintain liquidity and access capital/liquidity through their ultimate parent company, as needed. After making enquiries, and taking account of possible changes in performance, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. The Directors have received formal confirmation of support from the parent group for the 12 months from the date of signing the accounts and therefore continue to adopt the going concern basis in preparing its financial statements.”
Group structure
- DERMAVANT HOLDINGS LIMITED · parent
- Dermavant Sciences GmbH 100%
- Dermavant Sciences IRL Limited 100%
Significant events
- “On 28 October 2024, the Company, along with its subsidiaries and immediate parent, Dermavant Sciences Limited, were acquired by Organon & Co. As a result, the Company is now part of the Organon Group and the ultimate controlling party for the Company is Organon & Co.”
- “On 28 October 2024, as part of a group restructuring, the Company sold and transferred Dermavant Sciences Inc.(DSI) Shares to Dermavant Sciences Ltd. (DSL), for a purchase price in the amount of $86,000,000”
- “The accounting reference date has changed from 31 March to 31 December and accordingly the current year reflects a 9-month period from 1 April 2024 to 31 December 2024.”
- “Dermavant Sciences IRL Limited commenced the process of being liquidated (see Note 16: Subsequent Events). As such we have written off the value held in relation to this investment as an expense for this.period.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PARSONS, John Albert | Secretary | 2024-10-28 | — | — |
| BARR, Nicola | Director | 2025-09-01 | Aug 1976 | British |
| BITZER, Anne | Director | 2025-09-01 | Jan 1981 | French |
| LASKOWSKI, Josef Ralph | Director | 2024-10-28 | Oct 1980 | British |
| WHALE, Michael | Director | 2024-10-28 | Jan 1972 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JORDAN COMPANY SECRETARIES LIMITED | Corporate Secretary | 2016-08-08 | 2017-09-28 |
| VISTRA COSEC LIMITED | Corporate Secretary | 2017-09-28 | 2024-10-28 |
| JUER, Caterina Musgrave | Director | 2023-04-26 | 2024-10-28 |
| LINDSEY, Sandy | Director | 2024-10-28 | 2025-05-30 |
| MOORE, Lee Francis | Director | 2017-09-28 | 2024-10-28 |
| PALMER, Martin William Gordon | Director | 2018-01-30 | 2023-04-26 |
| ROMEO, Marianne | Director | 2016-08-08 | 2017-09-28 |
| VANDENBERK, Isabel | Director | 2024-10-28 | 2025-07-31 |
| VANT DIRECTOR SERVICES LIMITED | Corporate Director | 2017-09-28 | 2018-01-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Organon & Co. | Corporate entity | Shares 75–100%, Voting 75–100% | 2024-10-28 | Active |
| Roivant Sciences Ltd. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-10-01 | Ceased 2024-10-28 |
Filing timeline
Last 20 of 75 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-19 | AA | accounts | Accounts with accounts type full | |
| 2025-09-25 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-03 | AA01 | accounts | Change account reference date company previous shortened | |
| 2025-08-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-19 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-24 | AA | accounts | Accounts with accounts type full | |
| 2024-11-27 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2024-11-13 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-08 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-11-07 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-07 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-07 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-11-07 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-11-07 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-07 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-11-07 | PSC07 | persons-with-significant-control | Cessation of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2024 · period ending 2024-12-31 vs 2024-03-31